UK markets closed

LadRx Corporation (0I5R.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.0000-1.4600 (-59.35%)
At close: 06:49PM BST
Full screen
Previous close2.4600
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume18,900
Avg. volume250
Market cap309,278
Beta (5Y monthly)1.67
PE ratio (TTM)N/A
EPS (TTM)-0.3550
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    LadRx Issues 2024 Update to Shareholders

    LOS ANGELES, January 09, 2024--LadRx Corporation (OTCQB: LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today issued the below letter to shareholders providing a corporate update and anticipated milestones for 2024 regarding arimoclomol and LADR-7.

  • Business Wire

    LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation

    LOS ANGELES, June 22, 2023--LadRx Corporation (OTCQB: LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that it has transferred the royalty and milestone rights associated with arimoclomol and aldoxorubicin to XOMA Corporation (NASDAQ: XOMA) ("XOMA"). In exchange for the future rights to royalties and milestones on arimoclomol and aldoxorubicin, the agreement provides to LadRx $5 million in gros

  • Business Wire

    LadRx Announces Reverse Stock Split

    LOS ANGELES, May 10, 2023--LadRx Corporation (OTCQB: LADX) ("LadRx" or the "Company"), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares. The reverse stock split will become effective at 5:00 a.m. PDT on Wednesday, May 17, 2023. The Company’s common stock will continue to be traded on the OTC Capita